FDA Approves Carl Zeiss Meditec’s Cirrus HD-OCT for Dry AMD and Glaucoma

The FDA approved Carl Zeiss Meditec’s Cirrus HD-OCT software version 6.0 for dry age-related macular degeneration and glaucoma, according to a company news release.

Advertisement

The system includes Advanced Retinal Pigment Epithelium Analysis, which enables physicians to monitor changes associated with dry AMD, and Enhanced Depth Imaging, which allows physicians to better visualize deep tissues.

Related Articles on Ophthalmology:
Dr. Paul Lee Appointed Director of the W.K. Kellogg Eye Center at University of Michigan
Florida Eye Institute to Offer New and Expanded Range of Lens Implants for Cataract Patients
Scientists Develop Contact Lenses That Provide a Continuous Supply of Anesthetic for Laser Eye Surgery Patients

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.